News
22/10/2008
ADNA program receives approval from the European Commission up to € 90M
The ADNA Program (Advanced Diagnostics for New therapeutic Approaches), accredited by Lyonbiopôle in 2007, has just been given the European Commission's approval for an allocation of state research and innovation aid from OSEO in the amount of € 89.5M.
The ADNA program represents a total investment in research and development of nearly € 400M over the period of 2008-2017.
Coordinated by Mérieux Alliance, the ADNA program groups included 4 partners:
- BioMérieux and GenoSafe for the diagnosis
- Généthon and Transgene for the new therapies.










